Roivant Social Ventures Launches "Making Medicines" Course at the UNC Eshelman School of Pharmacy
Taught by Lindsay Androski, RSV Founder & CEO, & Scott Singleton, Associate Professor at the UNC Eshelman School of Pharmacy
This January RSV launched the "Making Medicines" course at the UNC Eshelman School of Pharmacy, the top ranked School of Pharmacy in the United States. The course is designed to teach PharmD students to understand and appreciate the new drug approval process and key issues in drug discovery, pre-clinical testing, clinical trials, FDA approval, and global access to medicines.
We would like to send a gracious thank you to our expert guest lecturers:
John Cox, Founder & Former CEO of Bioverativ (now part of Sanofi)
Anuj Hasija, Former VP of Global Marketing at Novartis Oncology
Dan Patterson, VP & Head of CMC, Biologics & Gene Therapies at Roivant Sciences & RSV Board Member
Clifford Samuel, Former SVP of Access Operations & Emerging Markets at Gilead Sciences & RSV Advisory Board Member
Pratik Shah, Former CEO of Auspex (now part of Teva)
Woody Sherman, Founder & CEO of Psivant
Jane Sohn, Staff Director of Nonprescription Drugs Pharmacology-Toxicology Staff, Office of Nonprescription Drugs, FDA
Bill Symonds, Co-Founder of Pharmasset (now part of Gilead Sciences) & Co-Founder of Roivant Sciences
It was a pleasure having these dynamic professionals share their real-world insights to inspire the next generation of PharmD leaders!